The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis.

Saved in:
Bibliographic Details
Title: The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis.
Authors: Groff KJ; Department of Neurosurgery, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA; Department of Pathology, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA., Patel RV; Department of Neurosurgery, Mass General Brigham and Harvard Medical School, Boston, MA, USA., Feng Y; Department of Biostatistics, NYU School of Global Public Health, New York, NY, USA., Ghosh HS; Department of Neurosurgery, Mass General Brigham and Harvard Medical School, Boston, MA, USA; Division of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA, USA., Millares Chavez MA; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA., O'Brien J; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA., Chen WC; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Nitturi V; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA., Save AV; Department of Neurosurgery, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA., Youngblood MW; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Horbinski CM; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Chandler JP; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Ehret F; Department of Radiation Oncology, Mass General Brigham and Harvard Medical School, Boston, MA, USA; Department of Radiation Oncology, Charité Universitätsmedizin Berlin Hospital with Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) Partner Site Berlin, Berlin, Germany., Gui C; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre at University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, University of Toronto, Toronto, ON, Canada., Wang JZ; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre at University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, University of Toronto, Toronto, ON, Canada., Park K; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Ajmera S; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Rosenblum M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Suwala AK; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK) and German Cancer Research Center (DFKZ), Heidelberg, Germany., Kresbach C; Department of Pediatric Hematology and Oncology and Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Mount CW; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Schüller U; Department of Pediatric Hematology and Oncology and Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Sahm F; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK) and German Cancer Research Center (DFKZ), Heidelberg, Germany., Bale TA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Jackson C; Department of Neurosurgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA., Richardson TE; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Cai C; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Nassiri F; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre at University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, University of Toronto, Toronto, ON, Canada., Zadeh G; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre at University Health Network and University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, University of Toronto, Toronto, ON, Canada; Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA., Kaul D; Department of Radiation Oncology, Charité Universitätsmedizin Berlin Hospital with Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) Partner Site Berlin, Berlin, Germany; Department of Radiation Oncology, Health and Medical University Potsdam, Potsdam, Germany., Capper D; Department of Neuropathology, Charité Universitätsmedizin Berlin Hospital with Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK) Partner Site Berlin, Berlin, Germany., Magill ST; Department of Neurological Surgery, Northwestern University, Chicago, IL, USA., Golfinos JG; Department of Neurosurgery, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA., Sen C; Department of Neurosurgery, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA., Patel AJ; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA; Department of Otolaryngology, Baylor College of Medicine, Houston, TX, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, USA., Raleigh DR; Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA; UCSF Brain Tumor Center and Department of Pathology, University of California, San Francisco, San Francisco, CA, USA., Moliterno J; Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA; The Chênevert Family Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA., Pacione D; Department of Neurosurgery, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA., Snuderl M; Department of Pathology, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Bi WL; Department of Neurosurgery, Mass General Brigham and Harvard Medical School, Boston, MA, USA. Electronic address: wbi@bwh.harvard.edu.
Source: The Lancet. Oncology [Lancet Oncol] 2025 Sep; Vol. 26 (9), pp. 1178-1190.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(25)00422-X